Novel Bacterium Isolated from a Lung Transplant Patient with Cystic Fibrosis

AUTOR(ES)

Pitulle, Christian

FONTE

American Society for Microbiology

RESUMO

The major clinical problem for patients with cystic fibrosis (CF) is progressive loss of pulmonary function, usually due to chronic bacterial infections. A patient with CF and a lung transplant was severely infected with a previously unidentified gram-negative bacterium. We isolated this organism (strain DS15158) from the patient and characterized it by phylogenetic analysis of the small-subunit rRNA and biochemically by the BIOLOG GN MicroPlate assay, fatty acid analysis, and various standard laboratory tests. No close match to any other organism could be found. Isolate DS15158 represents a new genus-level divergence within the bacterial subdivision α-Proteobacteria on the basis of the 16S rRNA gene analysis.

Documentos Relacionados

• Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.
• Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis.
• Expression Analysis of a Highly Adherent and Cytotoxic Small Colony Variant of Pseudomonas aeruginosa Isolated from a Lung of a Patient with Cystic Fibrosis†
• Organisms isolated from adults with Cystic Fibrosis
• Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period.